Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.
D000038:Abscess / Q000382:microbiology / Q000628:therapy*; D000293:Adolescent; D000900:Anti-Bacterial Agents; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003131:Combined Modality Therapy; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D004322:Drainage / Q000379:methods; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D011336:Probability; D011446:Prospective Studies; D018570:Risk Assessment; D018461:Soft Tissue Infections / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D013207:Staphylococcal Skin Infections / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D013211:Staphylococcus aureus / Q000302:isolation & purification*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents